Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Drug Survival of Anti Interleu...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Drug Survival of Anti Interleukin-17 and Interleukin -23 Agents after Adalimumab Failure in Hidradenitis Suppurativa: A Pilot Study

Drug Survival of Anti Interleukin-17 and Interleukin -23 Agents after Adalimumab Failure in Hidradenitis Suppurativa: A Pilot Study

Abstract is missing (Short communication)

Bibliographic Details
Main Authors: Federica Repetto, Gabriele Roccuzzo, Lorenza Burzi, Luca Mastorino, Paolo Dapavo, Pietro Quaglino, Simone Ribero
Format: Article
Language:English
Published: Medical Journals Sweden 2023-04-01
Series:Acta Dermato-Venereologica
Subjects:
Hidradenitis Suppurativa
Adalimumab
Risankizumab
Guselkumab
Secukinumab
Online Access:https://medicaljournalssweden.se/actadv/article/view/5278
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://medicaljournalssweden.se/actadv/article/view/5278

Similar Items

  • Efficacy and Safety of Risankizumab in Hidradenitis Suppurativa: A Case Series
    by: Federica Repetto, et al.
    Published: (2022-09-01)
  • Hidradenitis Suppurativa and JAK Inhibitors: A Review of the Published Literature
    by: Fabrizio Martora, et al.
    Published: (2023-04-01)
  • Adalimumab, Ustekinumab, and Secukinumab in the Management of Hidradenitis Suppurativa: A Review of the Real-Life Experience
    by: Martora F, et al.
    Published: (2023-01-01)
  • Long-Term Efficacy of Guselkumab in an Adolescent Hidradenitis Suppurativa Patients: A Case Report
    by: Martora F, et al.
    Published: (2024-02-01)
  • Secukinumab in Hidradenitis Suppurativa Patients Who Failed Adalimumab: A 52-Week Real-Life Study
    by: Martora F, et al.
    Published: (2024-01-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs